| Endocrine Assoc Of Ct Llc | |
|
1952 Whitney Ave Suite 14 Hamden CT 06517-1209 | |
| (203) 776-4444 | |
| (203) 776-4441 |
| Full Name | Endocrine Assoc Of Ct Llc |
|---|---|
| Speciality | Internal Medicine |
| Location | 1952 Whitney Ave, Hamden, Connecticut |
| Authorized Official Name and Position | Adam B Mayerson (PARTNER MEMBER) |
| Authorized Official Contact | 2037764444 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Endocrine Assoc Of Ct Llc 1952 Whitney Ave Suite 14 Hamden CT 06517-1209 Ph: (203) 776-4444 | Endocrine Assoc Of Ct Llc 1952 Whitney Ave Suite 14 Hamden CT 06517-1209 Ph: (203) 776-4444 |
| NPI Number | 1295929230 |
|---|---|
| Provider Enumeration Date | 09/04/2007 |
| Last Update Date | 02/18/2015 |
| Medicare PECOS PAC ID | 0840257192 |
|---|---|
| Medicare Enrollment ID | O20041217000563 |
News Archive
Benjamin Luft, M.D., Professor of Medicine, Stony Brook University Medical Center, and a team of medical researchers have determined the genetic blueprint of 13 strains of the bacteria that cause Lyme disease. The finding is crucial to advancing research on Lyme disease, the most frequent tick-borne infection in North America and Europe, and may lead to better diagnostics and a vaccine.
President Donald Trump's new pledge to crack down on "the global freeloading" in prescription drugs had a sense of déjà vu.
According to Pharmaion report, "United States Telemedicine Market Opportunities, 2011 - 2021", the telemedicine market in the United States is projected to cross $ 13 billion by 2021. Growth in the market is anticipated on account of increasing healthcare costs, growing aging population, and rising incidence of chronic diseases.
Lupin Pharmaceuticals has announced that on May 16, 2007 it received tentative approval from the US FDA for its Abbreviated New Drug Application (ANDA) for Ziprasidone Hydrochloride Capsules 20mg, 40mg, 60mg and 80mg.
› Verified 7 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295929230 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | (* (Not Available)) | Primary |
| Provider Name | Surani R Fernando |
|---|---|
| Provider Type | Practitioner - Endocrinology |
| Provider Identifiers | NPI Number: 1750355137 PECOS PAC ID: 2264416049 Enrollment ID: I20040617001185 |
News Archive
Benjamin Luft, M.D., Professor of Medicine, Stony Brook University Medical Center, and a team of medical researchers have determined the genetic blueprint of 13 strains of the bacteria that cause Lyme disease. The finding is crucial to advancing research on Lyme disease, the most frequent tick-borne infection in North America and Europe, and may lead to better diagnostics and a vaccine.
President Donald Trump's new pledge to crack down on "the global freeloading" in prescription drugs had a sense of déjà vu.
According to Pharmaion report, "United States Telemedicine Market Opportunities, 2011 - 2021", the telemedicine market in the United States is projected to cross $ 13 billion by 2021. Growth in the market is anticipated on account of increasing healthcare costs, growing aging population, and rising incidence of chronic diseases.
Lupin Pharmaceuticals has announced that on May 16, 2007 it received tentative approval from the US FDA for its Abbreviated New Drug Application (ANDA) for Ziprasidone Hydrochloride Capsules 20mg, 40mg, 60mg and 80mg.
› Verified 7 days ago
| Provider Name | Philip A Goldberg |
|---|---|
| Provider Type | Practitioner - Endocrinology |
| Provider Identifiers | NPI Number: 1659417889 PECOS PAC ID: 3577511294 Enrollment ID: I20050110000819 |
News Archive
Benjamin Luft, M.D., Professor of Medicine, Stony Brook University Medical Center, and a team of medical researchers have determined the genetic blueprint of 13 strains of the bacteria that cause Lyme disease. The finding is crucial to advancing research on Lyme disease, the most frequent tick-borne infection in North America and Europe, and may lead to better diagnostics and a vaccine.
President Donald Trump's new pledge to crack down on "the global freeloading" in prescription drugs had a sense of déjà vu.
According to Pharmaion report, "United States Telemedicine Market Opportunities, 2011 - 2021", the telemedicine market in the United States is projected to cross $ 13 billion by 2021. Growth in the market is anticipated on account of increasing healthcare costs, growing aging population, and rising incidence of chronic diseases.
Lupin Pharmaceuticals has announced that on May 16, 2007 it received tentative approval from the US FDA for its Abbreviated New Drug Application (ANDA) for Ziprasidone Hydrochloride Capsules 20mg, 40mg, 60mg and 80mg.
› Verified 7 days ago
| Provider Name | Karen M Moriarty |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1467666347 PECOS PAC ID: 5092720011 Enrollment ID: I20060213000636 |
News Archive
Benjamin Luft, M.D., Professor of Medicine, Stony Brook University Medical Center, and a team of medical researchers have determined the genetic blueprint of 13 strains of the bacteria that cause Lyme disease. The finding is crucial to advancing research on Lyme disease, the most frequent tick-borne infection in North America and Europe, and may lead to better diagnostics and a vaccine.
President Donald Trump's new pledge to crack down on "the global freeloading" in prescription drugs had a sense of déjà vu.
According to Pharmaion report, "United States Telemedicine Market Opportunities, 2011 - 2021", the telemedicine market in the United States is projected to cross $ 13 billion by 2021. Growth in the market is anticipated on account of increasing healthcare costs, growing aging population, and rising incidence of chronic diseases.
Lupin Pharmaceuticals has announced that on May 16, 2007 it received tentative approval from the US FDA for its Abbreviated New Drug Application (ANDA) for Ziprasidone Hydrochloride Capsules 20mg, 40mg, 60mg and 80mg.
› Verified 7 days ago
| Provider Name | Irina G Rosewater |
|---|---|
| Provider Type | Practitioner - Endocrinology |
| Provider Identifiers | NPI Number: 1477793529 PECOS PAC ID: 1456404912 Enrollment ID: I20090730000310 |
News Archive
Benjamin Luft, M.D., Professor of Medicine, Stony Brook University Medical Center, and a team of medical researchers have determined the genetic blueprint of 13 strains of the bacteria that cause Lyme disease. The finding is crucial to advancing research on Lyme disease, the most frequent tick-borne infection in North America and Europe, and may lead to better diagnostics and a vaccine.
President Donald Trump's new pledge to crack down on "the global freeloading" in prescription drugs had a sense of déjà vu.
According to Pharmaion report, "United States Telemedicine Market Opportunities, 2011 - 2021", the telemedicine market in the United States is projected to cross $ 13 billion by 2021. Growth in the market is anticipated on account of increasing healthcare costs, growing aging population, and rising incidence of chronic diseases.
Lupin Pharmaceuticals has announced that on May 16, 2007 it received tentative approval from the US FDA for its Abbreviated New Drug Application (ANDA) for Ziprasidone Hydrochloride Capsules 20mg, 40mg, 60mg and 80mg.
› Verified 7 days ago
| Provider Name | Adam B Mayerson |
|---|---|
| Provider Type | Practitioner - Endocrinology |
| Provider Identifiers | NPI Number: 1457451015 PECOS PAC ID: 7719944065 Enrollment ID: I20100209000216 |
News Archive
Benjamin Luft, M.D., Professor of Medicine, Stony Brook University Medical Center, and a team of medical researchers have determined the genetic blueprint of 13 strains of the bacteria that cause Lyme disease. The finding is crucial to advancing research on Lyme disease, the most frequent tick-borne infection in North America and Europe, and may lead to better diagnostics and a vaccine.
President Donald Trump's new pledge to crack down on "the global freeloading" in prescription drugs had a sense of déjà vu.
According to Pharmaion report, "United States Telemedicine Market Opportunities, 2011 - 2021", the telemedicine market in the United States is projected to cross $ 13 billion by 2021. Growth in the market is anticipated on account of increasing healthcare costs, growing aging population, and rising incidence of chronic diseases.
Lupin Pharmaceuticals has announced that on May 16, 2007 it received tentative approval from the US FDA for its Abbreviated New Drug Application (ANDA) for Ziprasidone Hydrochloride Capsules 20mg, 40mg, 60mg and 80mg.
› Verified 7 days ago
| Provider Name | Kai H Yang |
|---|---|
| Provider Type | Practitioner - Endocrinology |
| Provider Identifiers | NPI Number: 1093851321 PECOS PAC ID: 3577698257 Enrollment ID: I20100319000416 |
News Archive
Benjamin Luft, M.D., Professor of Medicine, Stony Brook University Medical Center, and a team of medical researchers have determined the genetic blueprint of 13 strains of the bacteria that cause Lyme disease. The finding is crucial to advancing research on Lyme disease, the most frequent tick-borne infection in North America and Europe, and may lead to better diagnostics and a vaccine.
President Donald Trump's new pledge to crack down on "the global freeloading" in prescription drugs had a sense of déjà vu.
According to Pharmaion report, "United States Telemedicine Market Opportunities, 2011 - 2021", the telemedicine market in the United States is projected to cross $ 13 billion by 2021. Growth in the market is anticipated on account of increasing healthcare costs, growing aging population, and rising incidence of chronic diseases.
Lupin Pharmaceuticals has announced that on May 16, 2007 it received tentative approval from the US FDA for its Abbreviated New Drug Application (ANDA) for Ziprasidone Hydrochloride Capsules 20mg, 40mg, 60mg and 80mg.
› Verified 7 days ago
| Provider Name | Shilpa Shetty |
|---|---|
| Provider Type | Practitioner - Endocrinology |
| Provider Identifiers | NPI Number: 1316194517 PECOS PAC ID: 3870617970 Enrollment ID: I20100826000205 |
News Archive
Benjamin Luft, M.D., Professor of Medicine, Stony Brook University Medical Center, and a team of medical researchers have determined the genetic blueprint of 13 strains of the bacteria that cause Lyme disease. The finding is crucial to advancing research on Lyme disease, the most frequent tick-borne infection in North America and Europe, and may lead to better diagnostics and a vaccine.
President Donald Trump's new pledge to crack down on "the global freeloading" in prescription drugs had a sense of déjà vu.
According to Pharmaion report, "United States Telemedicine Market Opportunities, 2011 - 2021", the telemedicine market in the United States is projected to cross $ 13 billion by 2021. Growth in the market is anticipated on account of increasing healthcare costs, growing aging population, and rising incidence of chronic diseases.
Lupin Pharmaceuticals has announced that on May 16, 2007 it received tentative approval from the US FDA for its Abbreviated New Drug Application (ANDA) for Ziprasidone Hydrochloride Capsules 20mg, 40mg, 60mg and 80mg.
› Verified 7 days ago
| Provider Name | Jean G Henry |
|---|---|
| Provider Type | Practitioner - Endocrinology |
| Provider Identifiers | NPI Number: 1023174745 PECOS PAC ID: 4981873668 Enrollment ID: I20110815000516 |
News Archive
Benjamin Luft, M.D., Professor of Medicine, Stony Brook University Medical Center, and a team of medical researchers have determined the genetic blueprint of 13 strains of the bacteria that cause Lyme disease. The finding is crucial to advancing research on Lyme disease, the most frequent tick-borne infection in North America and Europe, and may lead to better diagnostics and a vaccine.
President Donald Trump's new pledge to crack down on "the global freeloading" in prescription drugs had a sense of déjà vu.
According to Pharmaion report, "United States Telemedicine Market Opportunities, 2011 - 2021", the telemedicine market in the United States is projected to cross $ 13 billion by 2021. Growth in the market is anticipated on account of increasing healthcare costs, growing aging population, and rising incidence of chronic diseases.
Lupin Pharmaceuticals has announced that on May 16, 2007 it received tentative approval from the US FDA for its Abbreviated New Drug Application (ANDA) for Ziprasidone Hydrochloride Capsules 20mg, 40mg, 60mg and 80mg.
› Verified 7 days ago
| Provider Name | Agnieszka E Grochowalska |
|---|---|
| Provider Type | Practitioner - Endocrinology |
| Provider Identifiers | NPI Number: 1144496209 PECOS PAC ID: 2860665940 Enrollment ID: I20111107000006 |
News Archive
Benjamin Luft, M.D., Professor of Medicine, Stony Brook University Medical Center, and a team of medical researchers have determined the genetic blueprint of 13 strains of the bacteria that cause Lyme disease. The finding is crucial to advancing research on Lyme disease, the most frequent tick-borne infection in North America and Europe, and may lead to better diagnostics and a vaccine.
President Donald Trump's new pledge to crack down on "the global freeloading" in prescription drugs had a sense of déjà vu.
According to Pharmaion report, "United States Telemedicine Market Opportunities, 2011 - 2021", the telemedicine market in the United States is projected to cross $ 13 billion by 2021. Growth in the market is anticipated on account of increasing healthcare costs, growing aging population, and rising incidence of chronic diseases.
Lupin Pharmaceuticals has announced that on May 16, 2007 it received tentative approval from the US FDA for its Abbreviated New Drug Application (ANDA) for Ziprasidone Hydrochloride Capsules 20mg, 40mg, 60mg and 80mg.
› Verified 7 days ago
| Provider Name | Laurel H Brandon |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1770966095 PECOS PAC ID: 8426365164 Enrollment ID: I20150914001762 |
News Archive
Benjamin Luft, M.D., Professor of Medicine, Stony Brook University Medical Center, and a team of medical researchers have determined the genetic blueprint of 13 strains of the bacteria that cause Lyme disease. The finding is crucial to advancing research on Lyme disease, the most frequent tick-borne infection in North America and Europe, and may lead to better diagnostics and a vaccine.
President Donald Trump's new pledge to crack down on "the global freeloading" in prescription drugs had a sense of déjà vu.
According to Pharmaion report, "United States Telemedicine Market Opportunities, 2011 - 2021", the telemedicine market in the United States is projected to cross $ 13 billion by 2021. Growth in the market is anticipated on account of increasing healthcare costs, growing aging population, and rising incidence of chronic diseases.
Lupin Pharmaceuticals has announced that on May 16, 2007 it received tentative approval from the US FDA for its Abbreviated New Drug Application (ANDA) for Ziprasidone Hydrochloride Capsules 20mg, 40mg, 60mg and 80mg.
› Verified 7 days ago
| Provider Name | Kayla E Cunningham |
|---|---|
| Provider Type | Practitioner - Endocrinology |
| Provider Identifiers | NPI Number: 1609894534 PECOS PAC ID: 2062417793 Enrollment ID: I20161020001465 |
News Archive
Benjamin Luft, M.D., Professor of Medicine, Stony Brook University Medical Center, and a team of medical researchers have determined the genetic blueprint of 13 strains of the bacteria that cause Lyme disease. The finding is crucial to advancing research on Lyme disease, the most frequent tick-borne infection in North America and Europe, and may lead to better diagnostics and a vaccine.
President Donald Trump's new pledge to crack down on "the global freeloading" in prescription drugs had a sense of déjà vu.
According to Pharmaion report, "United States Telemedicine Market Opportunities, 2011 - 2021", the telemedicine market in the United States is projected to cross $ 13 billion by 2021. Growth in the market is anticipated on account of increasing healthcare costs, growing aging population, and rising incidence of chronic diseases.
Lupin Pharmaceuticals has announced that on May 16, 2007 it received tentative approval from the US FDA for its Abbreviated New Drug Application (ANDA) for Ziprasidone Hydrochloride Capsules 20mg, 40mg, 60mg and 80mg.
› Verified 7 days ago
| Provider Name | Kathryn M Peterson |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1750969705 PECOS PAC ID: 3476953522 Enrollment ID: I20210611001294 |
News Archive
Benjamin Luft, M.D., Professor of Medicine, Stony Brook University Medical Center, and a team of medical researchers have determined the genetic blueprint of 13 strains of the bacteria that cause Lyme disease. The finding is crucial to advancing research on Lyme disease, the most frequent tick-borne infection in North America and Europe, and may lead to better diagnostics and a vaccine.
President Donald Trump's new pledge to crack down on "the global freeloading" in prescription drugs had a sense of déjà vu.
According to Pharmaion report, "United States Telemedicine Market Opportunities, 2011 - 2021", the telemedicine market in the United States is projected to cross $ 13 billion by 2021. Growth in the market is anticipated on account of increasing healthcare costs, growing aging population, and rising incidence of chronic diseases.
Lupin Pharmaceuticals has announced that on May 16, 2007 it received tentative approval from the US FDA for its Abbreviated New Drug Application (ANDA) for Ziprasidone Hydrochloride Capsules 20mg, 40mg, 60mg and 80mg.
› Verified 7 days ago
| Provider Name | Anna Z Aranzullo |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1619623725 PECOS PAC ID: 5496141764 Enrollment ID: I20220413002376 |
News Archive
Benjamin Luft, M.D., Professor of Medicine, Stony Brook University Medical Center, and a team of medical researchers have determined the genetic blueprint of 13 strains of the bacteria that cause Lyme disease. The finding is crucial to advancing research on Lyme disease, the most frequent tick-borne infection in North America and Europe, and may lead to better diagnostics and a vaccine.
President Donald Trump's new pledge to crack down on "the global freeloading" in prescription drugs had a sense of déjà vu.
According to Pharmaion report, "United States Telemedicine Market Opportunities, 2011 - 2021", the telemedicine market in the United States is projected to cross $ 13 billion by 2021. Growth in the market is anticipated on account of increasing healthcare costs, growing aging population, and rising incidence of chronic diseases.
Lupin Pharmaceuticals has announced that on May 16, 2007 it received tentative approval from the US FDA for its Abbreviated New Drug Application (ANDA) for Ziprasidone Hydrochloride Capsules 20mg, 40mg, 60mg and 80mg.
› Verified 7 days ago
| Provider Name | Erwin V Nepomuceno |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1700504909 PECOS PAC ID: 9537535430 Enrollment ID: I20231220003664 |
News Archive
Benjamin Luft, M.D., Professor of Medicine, Stony Brook University Medical Center, and a team of medical researchers have determined the genetic blueprint of 13 strains of the bacteria that cause Lyme disease. The finding is crucial to advancing research on Lyme disease, the most frequent tick-borne infection in North America and Europe, and may lead to better diagnostics and a vaccine.
President Donald Trump's new pledge to crack down on "the global freeloading" in prescription drugs had a sense of déjà vu.
According to Pharmaion report, "United States Telemedicine Market Opportunities, 2011 - 2021", the telemedicine market in the United States is projected to cross $ 13 billion by 2021. Growth in the market is anticipated on account of increasing healthcare costs, growing aging population, and rising incidence of chronic diseases.
Lupin Pharmaceuticals has announced that on May 16, 2007 it received tentative approval from the US FDA for its Abbreviated New Drug Application (ANDA) for Ziprasidone Hydrochloride Capsules 20mg, 40mg, 60mg and 80mg.
› Verified 7 days ago
News Archive
Benjamin Luft, M.D., Professor of Medicine, Stony Brook University Medical Center, and a team of medical researchers have determined the genetic blueprint of 13 strains of the bacteria that cause Lyme disease. The finding is crucial to advancing research on Lyme disease, the most frequent tick-borne infection in North America and Europe, and may lead to better diagnostics and a vaccine.
President Donald Trump's new pledge to crack down on "the global freeloading" in prescription drugs had a sense of déjà vu.
According to Pharmaion report, "United States Telemedicine Market Opportunities, 2011 - 2021", the telemedicine market in the United States is projected to cross $ 13 billion by 2021. Growth in the market is anticipated on account of increasing healthcare costs, growing aging population, and rising incidence of chronic diseases.
Lupin Pharmaceuticals has announced that on May 16, 2007 it received tentative approval from the US FDA for its Abbreviated New Drug Application (ANDA) for Ziprasidone Hydrochloride Capsules 20mg, 40mg, 60mg and 80mg.
› Verified 7 days ago
David M. Stevenson Aprn Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 215 Sherman Ave, Hamden, CT 06518 Phone: 203-288-6800 Fax: 203-287-1953 | |
Hamden Medical Services Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2340 Whitney Ave, Hamden, CT 06518 Phone: 203-248-8142 Fax: 203-248-7764 | |
Gastroenterology Center Of Connecticut, Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2200 Whitney Ave, Suite 360, Hamden, CT 06518 Phone: 203-281-4463 Fax: 203-287-2914 | |
Margaret Chustecka Internal Medicine Of Greater New Haven Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1952 Whitney Ave, Hamden, CT 06517 Phone: 203-848-1803 Fax: 203-848-1777 | |
Express Care Urgent Care Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1650 Dixwell Ave, A, Hamden, CT 06514 Phone: 203-288-1700 Fax: 203-859-5392 | |
Whitney Internal Medicine Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2440 Whitney Ave, Hamden, CT 06518 Phone: 203-288-9650 Fax: 203-288-9670 | |
Imfp Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2447 Whitney Ave Ste 2a, Hamden, CT 06518 Phone: 203-230-5888 Fax: 203-230-5889 |